COLLU, GABRIELLA
 Distribuzione geografica
Continente #
EU - Europa 24.455
NA - Nord America 1.494
AS - Asia 192
SA - Sud America 1
Totale 26.142
Nazione #
IT - Italia 24.133
US - Stati Uniti d'America 1.491
CN - Cina 142
UA - Ucraina 118
SE - Svezia 92
DE - Germania 43
FI - Finlandia 33
KR - Corea 22
GB - Regno Unito 17
SG - Singapore 16
BE - Belgio 8
FR - Francia 7
VN - Vietnam 7
CA - Canada 3
IN - India 3
BG - Bulgaria 2
IR - Iran 2
AT - Austria 1
BR - Brasile 1
RU - Federazione Russa 1
Totale 26.142
Città #
Cagliari 24.058
Fairfield 221
Woodbridge 179
Houston 152
Chandler 133
Ashburn 100
Ann Arbor 96
Wilmington 89
Seattle 83
Jacksonville 74
Nyköping 74
Cambridge 73
Dearborn 48
Shanghai 29
Nanjing 26
Boardman 24
Helsinki 16
Beijing 15
Seoul 14
Boston 13
San Diego 12
Singapore 9
Brussels 8
Kunming 8
Changsha 7
Shenyang 7
Nanchang 6
Hebei 5
New York 5
Atlanta 4
Dong Ket 4
Gonnosfanàdiga 4
Jiaxing 4
Mountain View 4
Nürnberg 4
Sassari 4
Washington 4
Detroit 3
Edinburgh 3
Fuzhou 3
Guangzhou 3
Hanoi 3
Hefei 3
Jinan 3
Los Angeles 3
Milan 3
Redwood City 3
Taizhou 3
Auburn Hills 2
Chicago 2
Hangzhou 2
Orange 2
Selargius 2
Shenzhen 2
Sofia 2
Tappahannock 2
Tianjin 2
Toronto 2
Verona 2
Bengaluru 1
Borås 1
Gif-sur-yvette 1
Gunzenhausen 1
Hamedan 1
Hangyang 1
Jinhua 1
Kilburn 1
Leawood 1
London 1
Manchester 1
Miami 1
Ningbo 1
Norwalk 1
Ottawa 1
Pavia 1
Perugia 1
Phoenix 1
Piscataway 1
Pune 1
Vienna 1
Villa San Pietro 1
Wuhan 1
Wuxi 1
Totale 25.695
Nome #
Antiviral activity of benzotriazole derivatives. 5-[4-(Benzotriazol-2-yl)phenoxy]-2,2-dimethylpentanoic acids potently and selectively inhibit Coxsackie Virus B5 2.677
N-((1,3-Diphenyl-1H-pyrazol-4-yl)methyl)anilines: A novel class of anti-RSV agents 2.456
Unconventional Knoevenagel-type indoles: Synthesis and cell-based studies for the identification of pro-apoptotic agents 2.443
A combined in silico/in vitro approach unveils common molecular requirements for efficient BVDV RdRp binding of linear aromatic N-polycyclic systems 2.159
Inhibitors of Yellow Fever Virus replication based on 1,3,5-triphenyl-4,5-dihydropyrazole scaffold: Design, synthesis and antiviral evaluation. 1.808
Design, synthesis, antiviral evaluation, and SAR studies of new 1-(phenylsulfonyl)-1H-pyrazol -4-yl-methylaniline derivatives. 1.735
Aryl nucleoside H-phosphonates. Part 15: Synthesis, properties and, anti-HIV activity of aryl nucleoside 50-a-hydroxyphosphonates 1.134
Structure-based design, parallel synthesis, structure-activity relationship, and molecular modeling studies of thiocarbamates, new potent non-nucleoside HIV-1 reverse transcriptase inhibitor isosteres of phenethylthiazolylthiourea derivatives 1.095
null 950
null 896
null 895
null 857
null 833
null 832
null 786
null 760
null 717
null 694
Synthesis, Antitumor and Antiviral In Vitro Activities of New Benzotriazole-Dicarboxamide Derivatives 576
null 505
Parallel one-pot synthesis and structure-activity relationship study of symmetric formimidoester disulfides as a novel class of potent non-nucleoside HIV-1 reverse transcriptase inhibitors 266
Novel modifications in the series of O-(2-phthalimidoethyl)-N-substituted thiocarbamates and their ring-opened congeners as non-nucleoside HIV-1 reverse transcriptase inhibitors 161
Synthesis and anti-HIV-1 evaluation of 1,5-disubstituted pyrimidine-2,4-diones 153
Synthesis and in vitro evaluation of the anti-viral activity of N-[4-(1H(2H)-benzotriazol-1(2)-yl)phenyl]alkylcarboxamides 142
Parallel synthesis, molecular modelling and further structure-activity relationship studies of new acylthiocarbamates as potent non-nucleoside HIV-1 reverse transcriptase inhibitors 139
Synthesis and anti-Picornaviridae in vitro activity of a new class of helicase inhibitors the N,N’-bis[4-(1H(2H)-benzotriazol-1(2)-yl)phenyl]alkyldicarboxamides 121
Thiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 2: parallel synthesis, molecular modelling and structure-activity relationship studies on analogues of O-(2-phenylethyl)-N-phenylthiocarbamate 113
Synthesis of variously substituted 3-phenoxymethyl quinoxalin-2-ones and quinoxalines capable to potenziate in vitro the antiproliferative activity of anticancer drugs in multi-drug resistant cell lines 110
4-Substituted anilino imidazo[1,2-a] and triazolo[4,3-a]quinoxalines. Synthesis and evaluation of in vitro biological activity 109
Design, synthesis and anti Flaviviridae activity of N6-, 5’,3’-O- and 5’,2’-O-substituted adenine nucleoside analogs 106
Totale 26.228
Categoria #
all - tutte 31.934
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.934


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.311 0 0 53 70 2.789 1.886 923 172 94 49 77 198
2020/20217.090 134 223 229 2.902 1.599 688 367 330 89 253 180 96
2021/20221.481 162 143 52 77 125 147 85 93 133 101 164 199
2022/20232.014 226 272 218 137 180 221 108 97 132 138 189 96
2023/20242.100 76 100 99 127 218 322 353 164 95 129 204 213
2024/20251.108 419 576 113 0 0 0 0 0 0 0 0 0
Totale 26.228